ALS biotech Amylyx Pharmaceuticals has grown with CFO Frates’ help


Amylyx Pharmaceuticals has been on a tear since Jim Frates joined the Cambridge firm early in 2021.

Previous Elston quickly got EyePoint Pharmaceuticals on right path
Next Patti has done it all for Reading Cooperative Bank